Nuvectis Pharma, Inc.
NVCTNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $434.07M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.55$29.28
- Volume (live)
- -
- Avg. volume (3M)
- 201.06K
Nuvectis Pharma (NVCT) Stock Price & Financial Analysis
Nuvectis Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $17.69 - $20.41 |
|---|---|
| 52-Week High | $29.28 |
| 52-Week Low | $5.55 |
| Open | $20.00 |
| Volume (last close) | 318.83K |
| Average Volume (3M) | 201.06K |
| 50-Day MA | $21.65 |
|---|---|
| 200-Day MA | $14.18 |
| 1-Year Change | +249.08% |
| Market Cap | 434.07M |
|---|---|
| Shares Outstanding | 23.48M |
| Price to Book (P/B) | 47.79 |
| EV/EBITDA | -16.41 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Nuvectis Pharma at a Glance
As of the Oct 26, 2026 close, Nuvectis Pharma (NVCT) has a market capitalization of $434.07M.
As of its latest reported balance sheet, it holds $22.16M in cash and securities against $0.00 of debt, a net cash position of $22.16M.
Nuvectis Pharma does not currently pay a dividend.
The share price is up 249.1% over the past year. At $18.49 (the Oct 26, 2026 close) it sits within its 52-week range of $5.55 to $29.27, above its 200-day moving average of $14.18.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $34.33, 85.7% above the Oct 26, 2026 close.
Frequently Asked Questions About Nuvectis Pharma
What is the current stock price for NVCT?
As of the Oct 26, 2026 close, NVCT stock trades at $18.49. The 52-week range is $5.55–$29.28, with a day range of $17.69–$20.41.
What is the P/E ratio for NVCT?
The P/E ratio (Price-to-Earnings) for NVCT is shown in the Key Statistics section. This valuation metric helps compare Nuvectis Pharma, Inc. to industry peers.
Does NVCT pay dividends?
Nuvectis Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NVCT?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for NVCT is Buy. The average 12-month price target is $34.33, a 85.7% upside from the Oct 26, 2026 close of $18.49.
What is the market cap of NVCT?
As of the Oct 26, 2026 close, Nuvectis Pharma's market capitalization is $434.1M, classifying it as a small-cap company. Nuvectis Pharma operates in the Healthcare sector within the Biotechnology industry.